Muscle Dystrophies and Spinal Muscle Atrophy Flashcards

1
Q

Muscular Dystrophy

A
  • Definition: group of hereditary myopathies
  • Characteristics:
    • Progressive muscle weakness, deterioration, destruction, and regeneration of muscle fibers
    • Muscle fibers gradually replaced by fibrous and fatty tissues
  • Types
    • Beckers dystrophy
    • Myotonic dystrophy
    • Limb girdle dystrophy
    • Facioscapulohumeral dystrophy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Congenital/myotonic muscular dystrophy

A

birth

dominant

Typically slow with significant intellectual impairment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Duchenne’s Muscular Dystrophy

A
  • Incidence
    • One of the most prevalent and disabling types of MD
    • Between 1/3500 male births
  • Prognosis
    • Mortality usually due to respiratory or cardiorespiratory insufficiency
    • Many are surviving into their 30s
      • New challenges for therapy, education, and vocation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Etiology Duchenne’s Muscular Dystrophy

A
  • Sex linked recessive disorder
  • Abnormality on X chromosome at band Xp21
  • Results in a disorder of encoding dystrophin and dystrophin associated proteins (DAP)
  • Dystrophin acts as an anchor in the intracellular lattice to enhance tensile strength
  • If dystrophin is absent from the muscle 🡪 fragility in the muscle membrane during muscle contraction + relative muscle hypoxia as a result of an aberrant vascular response to exercises
  • Early breakdown of muscle fiber plasma membrane
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Duchenne’s Muscular Dystrophy Characteristics

A
  • Creatine kinase is elevated early in the disease
    • Present at birth long before symptoms are present
  • Muscle biopsy shows degeneration with loss of fibers, variation in fiber size, and a proliferation of connective and adipose tissue
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Duchenne’s Muscular Dystrophy: Clinical Presentation

A
  • Insidious onset
    • May be misdiagnosed
  • Early symptoms
    • Reluctance to walk/run at appropriate ages
    • Falling
    • Difficulty with stairs
    • Toe walking
    • Clumsiness
    • Pseudohypertrophy
      • Gastroc
      • Deltoids
      • Quads
      • Forearm extensors
    • Proximal muscles weak early on
    • Weakness of hip and knee extensors early
  • Gower’s sign
    • Initial weakness of the neck/trunk flexors, hip extensors, and interscapular muscles
  • Intellectual impairment
  • Emotional disturbance
  • With progression
    • Exaggerated lordosis
    • Wide BOS
    • Waddling gait
    • ITB contracture
    • Heel cord contracture
  • Loss of unassisted ambulation at ages 9-10
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Duchenne’s Muscular Dystrophy: Medical Intervention

A
  • Steroids
    • Prolong life by 3 years
    • Improve isometric UE strength by 60%
    • Improve isometric LE strength by 85%
    • Improve pulmonary and cognitive function
    • Side effects
      • Weight gain
      • Growth suppression
      • Cataracts
      • Osteoporosis
  • Other interventions
    • Myoblast transplant
    • Gene therapy
    • Cell based replacement therapy
    • Creatine
      • Improved muscle strength/endurance
      • Less joint stiffness
  • Surgical interventions
    • Muscle releases (Achilles, fasciotomy of TFL/ITB)
    • Scoliosis stabilization
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Prognostic factors Duchenne’s Muscular Dystrophy

A
  • Timed functional activities closely related to muscle strength and predictive of loss of ambulation
    • 10M walk/run time greater than 9 seconds predicts loss of ambulation within 2 years
    • Inability to rise from the floor predicts loss of ambulation within 2 years
    • 10M walk/run time greater than 12 seconds predicts loss of ambulation within a year
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Duchenne’s Muscular Dystrophy: Evidence Based Tests and Measures

A
  • Northstar Ambulatory Assessment
  • The Performance of Upper Limb for Duchenne
  • Brook Scale
  • Vignos Scale
  • Egen Klassifikation Scale
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Vignos Scale

A

1-10 scale with 1 being able to walk and climb stairs without assistance and 10 being confined to bed.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Duchenne’s Muscular Dystrophy: PT Role

A
  • Early diagnosis
  • Education, referral, and support for the family
  • Weight control
  • Sleep and respiratory concerns
  • B&B concerns
  • Goals
    • Prolong function
    • Prevent contractures/deformities
    • Adapt equipment
    • Encourage peer and community interaction
    • Pain control
      • Many experience spasms and pain
      • Massage and gentle stretching appear to help
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

DMD: Interventions for Infancy-Preschool Age

A
  • Characteristics
    • May see developmental delay related to weakness
    • Mild tightness of the gastroc/TFL
  • PT goals
    • Family support and education
    • Consider daily ROM and night splinting
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

DMD: Interventions for Early School Age Period Characteristics

A
  • Characteristics
    • Limitations in activity more apparent
      • Clumsiness
      • Falling
      • Difficulty with stairs
      • Rising to standing/running
      • Gait deviations
        • Increased BOS
        • Compensated Trendelenburg
        • Toe walking
        • Lordosis with shoulder retraction
        • Lack of arm swing
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

DMD: Interventions for Early School Age Period

A
  • Family support and education
  • Obtain baseline data on ROM/MMT
  • Strength and exercise
    • Widely accepted that eccentric exercise and immobilization are detrimental
    • Key muscles: abdominals, hip ext/abd, knee extensors
  • Maintain ROM/flexibility
    • May not be able to prevent contractures, but can slow development
    • Key muscles: gastrocs, HS, and TFL
    • 1-2x daily, 10 reps, 30-60 seconds
    • Night splints in combination with daily stretching most effective; can prolong ambulation
  • Cycling, swimming, and standing for 2-3 hours daily
  • Respiratory function
    • Measure RR
    • Chest wall excursion
    • Coughing
    • Secretion clearing
    • Spirometry
    • Breathing exercises
    • Inspiratory muscle training
  • Monitor progression
  • Consider need for other mobility options (MWC, scooters, PWC)
    • Risk for falls if ambulation continues past when it is feasible
    • Risk for scoliosis increases once the child is nonambulatory
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

DMD: Interventions for Adolescent Period

A
  • Impairments
    • Considerable deterioration in function
      • Loss of walking
      • Reliance of powered mobility
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

DMD: Interventions for Adolescent Period

A
  • UE considerations
    • Encourage participation in ADLs as much as possible
      • May need adaptive equipment for self feeding
    • UE ergometry program
    • Focus on maintenance of muscles needed for transfers
  • LE considerations
    • Gentle stretching (may add hip flexors, long finger flexors, shoulder, elbow, forearm, and wrist musculature)
  • Respiratory function
    • Position of the spine is crucial: N to slightly extended is best to prevent scoliosis (loads facet joints and prevents rotation and lateral flexion)
17
Q

DMD: Interventions for Adolescent Period

A
  • Continuation of standing/walking
    • Standers strongly encouraged
    • Walking programs
      • KAFOs with standby assistance
    • Bracing/therapeutic walking based on
      • Obesity
      • Residual muscle strength
      • Absence of severe contractures
      • Timely application of braces
      • Motivation of the family/child
  • Surgical correction
    • May be necessary to prolong ambulation
    • Personal decision
18
Q

DMD: Interventions for Adolescent Period 2

A
  • Equipment
    • Functional mobility
      • Stand pivot transfers will be replaced by one or two person lifts / lift equipment
    • Sliding board is not appropriate
      • UE weakness
    • Toilet and shower equipment
    • Powered mobility
      • Transition from powered scooter to standard power chair
        • Needed for use on buses, cars, etc.
    • Consider a urinal to decrease the need for transfers
    • Airflow mattress, egg crate, or memory foam/hospital bed
19
Q

DMD: Interventions for Adults

A
  • Respiratory considerations
    • After age 18, FVC and PEF decline
    • Respiratory failure/infection are common contributing factors to death
    • Assisted ventilation can prolong life
      • Daytime intermittent positive pressure ventilation via mask / nasal cannula
      • Nocturnal bilevel positive airway pressure (BiPAP)
      • Negative pressure ventilators
      • Suctioning
    • Breathing exercises
    • Postural drainage
20
Q

3 types of spinal muscle atrophy

A

infantile werdnig hoffman

intermediate type 2

juvenile Kugelberg-Welander

21
Q

Spinal Muscular Atrophy etiology and characteristics

A
  • Etiology
    • All are autosomal recessive disorders
    • Located on chromosome 5
    • Affect the anterior horn
  • Characteristics
    • Wasting and weakness of the muscles
    • No sensory disturbances
22
Q

diagnosis for spinal muscle atrophy

A
  • Clinical presentation
  • EMG
    • Denervation with fibrillations and a paucity of motor units
  • Muscle biopsy
  • Muscle ultrasound
  • Genetic testing
  • Normal cardiac tissue
23
Q

SMA Special Examinations to Consider

A
  • Clinical presentation
  • EMG
    • Denervation with fibrillations and a paucity of motor units
  • Muscle biopsy
  • Muscle ultrasound
  • Genetic testing
  • Normal cardiac tissue
24
Q

SMA type 1 onset, characteristics, mortality

A
  • Onset: almost always noted in the first 3 months of life
  • Characteristics
    • Decreased fetal movement
    • Hypotonia but appear alert and responsive
    • Difficulty feeding
    • Respiratory distress
    • Muscle wasting
    • Few spontaneous movements
    • DTRs decreased or absent
  • Mortality
    • Limited lifespan
    • Respiratory failure
      • Dependent on aggressiveness of treatment
25
Q

Type I: Infantile Werdnig-Hoffman secondary impairments, PT goals

A
  • Secondary impairments
    • Scoliosis
    • Contractures
    • Decreased respiratory capacity
    • Fatiguability
  • PT goals
    • ROM
    • Feeding
    • Positioning
    • Respiratory care
    • Select developmental activities
    • Assistive technology
    • Limited use of prone due to difficulty lifting head, inhibition of abdominal expansion and diaphragmatic depression
    • Breathing may become difficult in upright as well
26
Q

SMA type 2 onset, characteristics, goals

A
  • Onset
    • Usually diagnosed at 3-6 months of age
    • Also affects infants, but not as severely
  • Characteristics
    • Floppy, slow to develop motor milestones
    • Weak trunk/extremities with muscle atrophy
    • Few have feeding problems
    • Fine extremity tremors
    • May or may not learn to walk
    • Most require orthotic intervention
  • PT Goals
    • Encourage stance
    • Prevent deformity
    • Respiratory interventions
    • Adapt play/writing tools
27
Q

SMA Type III: Juvenile Kugelberg-Welander

A
  • Onset
    • Diagnosed between 1 and 10 y/o
  • Characteristics
    • Slowly progressive weakness
      • Mild impairment
    • Proximal muscles are usually involved first